December 24, 2015

KaloBios CFO, Accounting Firm Resign After Shkreli's Arrest
Bloomberg News – Dec. 23
KaloBios trading was halted the day of the arrest and hasn’t resumed. Last weekend, the University of California at Davis and Moffitt Cancer Center in Florida said they had suspended plans to participate in a drug trial sponsored by KaloBios.

Are Academic Cancer Centers a National Treasure?
The Asco Post – Dec. 23
The Ohio State University Comprehensive Cancer Center and Moffitt Cancer Center were founding partners in the Oncology Research Information Exchange Network.

100 year old chemical could be the future of cancer treatment
Pharmafile – Dec. 23
It is this that makes PV-10 a particularly exciting prospect in cancer therapy. Provectus is studying this mechanism of action in combination with the Moffitt Cancer Centre and Research Institute, and recently-presented data showing that tumour-specific T cells were increased in the blood after tumour ablation with PV-10.  

Genetic Test Finds Radiation Sensitivity Differs Between Primary Tumor and Metastatic Sites
Journal of the National Center Institute – December 2015
“Right now, we know clinically that patients have different responses to radiation, but the way we treat them doesn’t acknowledge that,” said study coauthor Javier F. Torres-Roca, M.D., a radiation oncologist at the Moffitt Cancer Center and Research Institute in Tampa, Fla. “Our focus is integrating genomic measures into radiation oncology, not only to understand the mechanisms of the problem but to find ways to treat patients more effectively.” 

Post-Cystectomy Complications Linked to Poor Mental Health
Renal & Urology News – Dec. 22
“Prior studies have suggested that poor baseline mental health can lead to more significant postoperative complications possibly due to impaired immune response associated with higher levels of stress,” lead researchers Scott M. Gilbert, MD, MS, of the H. Lee Moffitt Cancer Center in Tampa, Fla., explained in a press release.

Moffitt Cancer Center suspends drug study linked to arrested pharmaceuticals executive
Tampa Bay Times – Dec. 22
Tampa's Moffitt Cancer Center is suspending a clinical trial sponsored by KaloBios Pharmaceuticals, a California biotechnology company that was run by entrepreneur Martin Shkreli until his arrest last week on fraud charges.

CAR T-Cell Therapy KTE-C19 Shows Promise in Non-Hodgkin Lymphoma
OncLive – Dec. 22
To learn more about the potential for KTE-C19 in NHL, OncLive spoke with study lead study author Frederick Locke, MD, a medical oncologist in the Department of Blood and Marrow Transplant at Moffitt Cancer Center, and an assistant professor of Oncology at the University of South Florida.

Turing exec Martin Shkreli calls fraud charges ‘baseless and without merit’
The Oracle Herald – Dec. 22
The University of California at Davis and Moffitt Cancer Center in Florida on Saturday said they were suspending a clinical trial, sponsored by KaloBios, of the leukemia drug KB003 due to Shkreli's criminal case. Its shares tumbled 70 percent in January after its drug for lung infections failed in testing.

Leading Registered Nurse Gloritza Martinez, RN to be Published in the Worldwide Leaders in Healthcare as New Member of the International Nurses Association
Before Its News – Dec. 22
The International Nurses Association is pleased to welcome Gloritza Martinez, RN to their prestigious organization with her upcoming publication in the Worldwide Leaders in Healthcare. Gloritza is a registered nurse at H. Lee Moffitt Cancer Center & Research Institute in Tampa, FL. She has over 17 years of experience specializing in oncology.

Martin Shkreli fired from drug firm KaloBios following arrest
NYSE Post – Dec. 22
The University of California at Davis and Moffitt Cancer Center in Florida on Saturday said they were suspending a clinical trial, sponsored by KaloBios, of the leukemia drug KB003 due to Shkreli's criminal case.

Shkreli: indictment unfair, doesn’t tell my side
CNBC – Dec. 21
The University of California at Davis and Moffitt Cancer Center in Florida on Saturday said they were suspending a clinical trial, sponsored by KaloBios, of the leukemia drug KB003 due to Shkreli's criminal case.

UPDATED: Fired by KaloBios, a chastened Martin Shkreli claims bad boy persona was just an 'experiment'
FierceBiotech – Dec. 21
"Moffitt Cancer Center was among several participating sites of the clinical trial 'Study of KB003 in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)' funded by KaloBios," a spokesperson for the research center told FierceBiotech in a statement.

Drug company CEO released on $5 million bond
KJRC NBC –Dec. 21
In a statement, Moffitt Cancer Center says it's stopping it indefinitely pending the outcome of the case.

Cancer Drug Clinical Trial Cancelled after Martin Shkreli Arrest
Drug, Discovery and Development – Dec. 21
The University of California Davis (UC Davis) and Florida-based Moffitt Cancer Research Center were set to take part in this trial, which was to be sponsored by KaloBios Pharmaceutical.

Notorious Pharma CEO Is No Longer a Pharma CEO
Newser – Dec. 21
Bloomberg reports that a clinical leukemia drug trial sponsored by KaloBios has been suspended by the University of California at Davis and Florida's Moffitt Cancer Center.

UC Davis suspends drug trial after CEO Shkreli’s arrest,” by Bloomberg’s Stephen West: Politico – Dec. 21
The University of California at Davis and Moffitt Cancer Center in Florida have suspended a planned drug trial sponsored by KaloBios Pharmaceuticals Inc. following the arrest of Chief Executive Officer Martin Shkreli on securities fraud charges.

Drug company CEO released on $5 million bond
KJRC NBC –Dec. 21
In a statement, Moffitt Cancer Center says it's stopping it indefinitely pending the outcome of the case.

‘Most hated CEO’ resigns from Turing Pharmaceuticals
Steelers Lounge - Dec. 21
The University of California at Davis and Moffitt Cancer Center in Florida have suspended a planned drug trial sponsored by KaloBios Pharmaceuticals Inc. following the arrest of Chief Executive Officer Martin Shkreli on securities fraud charges.

Compound targets hard-to-treat breast cancer
Technology Networks – Dec. 21
The study was a collaboration among the Florida labs of Derek Duckett and William R. Roush, both of TSRI, and John Cleveland, formerly of TSRI and currently at the Moffitt Cancer Center.

Fallout Continues for 'Most Hated Man in America' Now Out on Bail
NBC Nightly News – Dec. 20
In a statement, Moffitt Cancer Center saying it’s stopping this clinical trial indefinitely pending the outcome of the investigation of Shkreli.

Bad-boy ex-pharma CEO Shkreli calls fraud charges 'baseless'
CNBC – Dec. 20
Shkreli’s arrest may have implications for the development of certain drug patents it holds. On Sunday, Moffitt Cancer Center released a statement saying it had suspended clinical trials of a drug held by KaloBios, another company run by Shkreli.

Martin Shkreli's Arrest Halts Leukemia Drug Trial
Fortune – Dec. 20
According to Bloomberg, the University of California at Davis and the Moffitt Cancer Center in Florida have suspended their trials. It is uncertain whether trials at five other clinics—the Mayo Clinic, Cleveland Clinic, University of Miami’s Sylvester Cancer Center, Weill Cornell Medical College, and Northwestern University’s Lurie Comprehensive Cancer Center—will be halted as well. This story was also shared on TIME’s website.

KaloBios Pharmaceuticals Inc (KBIO) Drug Trial Suspended By UC Davis As Shkreli Speaks
IR.net – Dec. 20
KaloBios Pharmaceuticals’ (NASDAQ:KBIO) trial for a leukemia drug called KB003 has been suspended by the University of California at Davis and Moffitt Cancer Center in Florida after they heard about the company’s CEO Martin Shkreli’s arrest last week.

Martin Shkreli attributes arrest to drug-price hikes
Celb Café – Dec. 20
The University of California at Davis and Moffitt Cancer Center in Florida have suspended a planned drug trial sponsored by KaloBios Pharmaceuticals Inc. following the arrest of Chief Executive Officer Martin Shkreli on securities fraud charges.

Moffitt Dedication: Gruden Huddle Room
Bay News 9 –Dec. 20
A special dedication at Moffitt Cancer Center in Tampa.  Aroom there-- honors former Bucs coach Jon Gruden.. and his wife Cindy. It's called the "Gruden Huddle Room." it's located at the Moffitt Mckinley outpatient center. 

UC Davis Suspends KaloBios Drug Trial After CEO Shkreli's Arrest
Bloomberg – Dec. 19
The University of California at Davis and Moffitt Cancer Center in Florida have suspended a planned drug trial sponsored by KaloBios Pharmaceuticals Inc. following the arrest of Chief Executive Officer Martin Shkreli on securities fraud charges.

Cancer diagnosis triggers need
The Lakeland Ledger – Dec. 19
Surgeons have removed several large tumors from her colon and left ovary but living with the disease means ongoing chemotherapy and biweekly visits to the Moffitt Cancer Center in Tampa.

Hospital staff sports blue mustaches to support cancer victim
WFLA – Dec. 18
Their little 11-year-old boy, Corbin, had metastatic melanoma, an aggressive form of skin cancer. Before Corbin’s first surgery, Moffitt Cancer Center’s Dr. Wayne Cruz decided to draw something silly across Corbin’s face with that blue marker that is typically used to mark surgical incisions.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.